Publications by authors named "Virginie Decaulne"
Biomark Insights
March 2018
Article Synopsis
- MiR-31-3p is identified as a potential biomarker for predicting how well patients with RAS wild-type metastatic colorectal cancer respond to anti-EGFR therapy.
- A new RT-qPCR assay was developed and validated to measure miR-31-3p levels in formalin-fixed paraffin-embedded tumor samples.
- The study confirmed that the assay is reliable, with consistent performance across various conditions and PCR platforms, indicating it's feasible to quantify miR-31-3p in clinical samples.
